Carlit (4275) Q1 2027 earnings summary

Executive summary

• Net sales remained flat year-over-year at ¥8,654 million for Q1 FY2027, with gross profit up 3.7% to ¥1,983 million.

• Operating profit declined 42.7% to ¥255 million, mainly due to higher distribution and administrative expenses.

• Net profit dropped 77% year-over-year to ¥68 million, impacted by increased corporate income tax from a subsidiary sale.

• Comprehensive income fell 92.4% to ¥74 million.

• The company is in the “Investment Promotion” stage of its medium-term plan, with major capital projects underway in chemicals and bottling.

Financial highlights

• Gross profit improved by ¥72 million year-over-year, driven by product mix optimization and cost reductions.

• Distribution and administrative expenses rose by ¥262 million (+17.8%), offsetting gross profit gains.

• Ordinary profit decreased by 33.7% to ¥385 million year-over-year.

• Basic EPS was ¥3.10, down from ¥12.79 year-over-year.

• Depreciation for Q1 FY2027 was ¥471 million, up from ¥420 million year-over-year.

Outlook and guidance

• No changes to the full-year earnings forecast; consolidated earnings are progressing as planned.

• Full-year net sales forecasted at ¥37,200 million (+2.6% year-over-year), with net profit expected at ¥3,000 million (+0.8%).

• Operating profit for the full year is forecasted to decline by 7.4%–7.5% due to production line shutdowns and higher raw material costs.

• Dividend per share is projected to remain at ¥42.

• Bottling segment expected to recover after Q3 as renovation work concludes; Chemical Products segment to be supported by electronic materials and ammonium perchlorate.